Biomarin Pharmaceutical Inc. - Registered Shares

NASDAQ:BMRN   2:40:31 PM EDT
103.31
-1.08 (-1.03%)
Products

Biomarin Resubmits Biologics License Application For Valoctocogene Roxaparvovec AAV Gene Therapy To The FDA

Published: 09/29/2022 20:16 GMT
Biomarin Pharmaceutical Inc. - Registered Shares (BMRN) - Biomarin Resubmits Biologics License Application (bla) for Valoctocogene Roxaparvovec Aav Gene Therapy for Severe Hemophilia a to the FDA.
Biomarin Pharmaceutical Inc - Bla Includes Substantial Body of Data From Pivotal Phase 3 and Ongoing Phase 1/2 Studies.